INCY:NASDAQ
Incyte Corp
$123.20
arrow_downward
-1.30%(-1.62) 1D
$123.01
arrow_downward
-0.16% (-0.19)bedtimeAfter hours
Closed: Sep 29, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$123.67
High
$125.47
Low
$121.89
Mkt. cap
24.97B
Avg. vol.
1.42M
Volume
1.71M
P/E ratio
15.70
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$123.67
High
$125.47
Low
$121.89
Mkt. cap
24.97B
Avg. vol.
1.42M
Volume
1.71M
P/E ratio
15.70
52-wk high
$132.58
52-wk low
$82.82
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
News Corp
·
19 minutes ago
Incyte Corp. stock underperforms Tuesday when compared to competitors
AD HOC NEWS
·
10 hours ago
Incyte stock trades at EUR 110.18 after an Atebrioz target hike
Simply Wall Street
·
17 hours ago
Incyte (INCY), What Is Behind The Fresh Attention?
GuruFocus
·
1 day ago
INCY Maintained by JP Morgan -- Price Target Raised to $123.00
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com